These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7651894)

  • 41. The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium.
    Han ZQ; Coppock HA; Smith DM; Van Noorden S; Makgoba MW; Nicholl CG; Legon S
    J Mol Endocrinol; 1997 Jun; 18(3):267-72. PubMed ID: 9195480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of calcitonin gene-related peptide (CGRP) in macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cells.
    Owan I; Ibaraki K
    Bone Miner; 1994 Feb; 24(2):151-64. PubMed ID: 8199534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors.
    Zhu GC; Dudley DT; Saltiel AR
    Biochem Biophys Res Commun; 1991 Jun; 177(2):771-6. PubMed ID: 1646609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
    Van Rossum D; Ménard DP; Fournier A; St-Pierre S; Quirion R
    J Pharmacol Exp Ther; 1994 May; 269(2):846-53. PubMed ID: 8182554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Desensitization of adrenomedullin and calcitonin gene-related peptide receptors in vascular smooth muscle cells--effects of receptor activity-modifying protein.
    Qi YF; Xue L; Chai SB; Shi YR; Pang YZ; Tang CS
    Sheng Li Xue Bao; 2001 Oct; 53(5):396-400. PubMed ID: 11833426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells.
    Husmann K; Born W; Fischer JA; Muff R
    Biochem Pharmacol; 2003 Dec; 66(11):2107-15. PubMed ID: 14609735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D; Cornish J
    Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct inhibitory effect of adrenomedullin, calcitonin gene-related peptide, calcitonin, and amylin on cholecystokinin-induced contraction of guinea-pig isolated caecal circular smooth muscle cells.
    Ochiai T; Chijiiwa Y; Motomura Y; Yasuda O; Harada N; Nawata H
    Peptides; 2001 Jun; 22(6):909-14. PubMed ID: 11390020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adrenomedullin stimulates nitric oxide release from SK-N-SH human neuroblastoma cells by modulating intracellular calcium mobilization.
    Xu Y; Krukoff TL
    Endocrinology; 2005 May; 146(5):2295-305. PubMed ID: 15677761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of CGRP receptors in various regions of gerbil brain.
    Aiyar N; Baker E; Nambi P; Feuerstein G; Willette R
    Neuropeptides; 1994 May; 26(5):313-7. PubMed ID: 8065549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcitonin gene-related peptide (CGRP) increases intracellular free Ca2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4).
    Drissi H; Lieberherr M; Hott M; Marie PJ; Lasmoles F
    Cytokine; 1999 Mar; 11(3):200-7. PubMed ID: 10209067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins.
    Kuwasako K; Kitamura K; Nagoshi Y; Eto T
    Biochem Biophys Res Commun; 2003 Feb; 301(2):460-4. PubMed ID: 12565884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster.
    Hall JM; Siney L; Lippton H; Hyman A; Kang-Chang J; Brain SD
    Br J Pharmacol; 1995 Feb; 114(3):592-7. PubMed ID: 7735685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and characterization of calcitonin gene-related peptide receptors in porcine renal medullary membranes.
    Aiyar N; Nambi P; Griffin E; Bhatnagar P; Feuerstein G
    Endocrinology; 1991 Aug; 129(2):965-9. PubMed ID: 1649752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain.
    van Rossum D; Ménard DP; Fournier A; St-Pierre S; Quirion R
    J Pharmacol Exp Ther; 1994 Aug; 270(2):779-87. PubMed ID: 8071870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene-related peptide receptors.
    Taylor GM; Meeran K; O'Shea D; Smith DM; Ghatei MA; Bloom SR
    Endocrinology; 1996 Aug; 137(8):3260-4. PubMed ID: 8754748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat.
    Champion HC; Lambert DG; McWilliams SM; Shah MK; Murphy WA; Coy DH; Kadowitz PJ
    Regul Pept; 1997 Jun; 70(2-3):161-5. PubMed ID: 9272628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor.
    Shi L; Lehto SG; Zhu DX; Sun H; Zhang J; Smith BP; Immke DC; Wild KD; Xu C
    J Pharmacol Exp Ther; 2016 Jan; 356(1):223-31. PubMed ID: 26559125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.